(Q51937010)

17 April 2018

title

MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. (English)

1 reference

17 April 2018

magnetic resonance imaging

1 reference

0 references

author

Jochen B Fiebach

3

1 reference

17 April 2018

Peter A Ringleb

7

1 reference

17 April 2018

author name string

Martin Köhrmann

1

1 reference

17 April 2018

Eric Jüttler

2

1 reference

17 April 2018

Hagen B Huttner

4

1 reference

17 April 2018

Stefan Siebert

5

1 reference

17 April 2018

Christian Schwark

6

1 reference

17 April 2018

Peter D Schellinger

8

1 reference

17 April 2018

Werner Hacke

9

1 reference

17 April 2018

publication date

1 August 2006

1 reference

17 April 2018

published in

Lancet Neurology

1 reference

17 April 2018

volume

5

1 reference

17 April 2018

issue

8

1 reference

17 April 2018

page(s)

661-667

1 reference

17 April 2018

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Effect of Intravenous Thrombolysis on MRI Parameters and Functional Outcome in Acute Stroke <6 Hours

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Audit of a policy of magnetic resonance imaging with diffusion-weighted imaging as first-line neuroimaging for in-patients with clinically suspected acute stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Comparison of MRI and CT for detection of acute intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Imaging-guided extension of the time window: ready for application in experienced stroke centers?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

European Stroke Initiative Recommendations for Stroke Management – Update 2003

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

MRI screening before standard tissue plasminogen activator therapy is feasible and safe.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

The use of PWI and DWI measures in the design of "proof-of-concept" stroke trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

The fate of hypoxic tissue on18F-fluoromisonidazole positron emission tomography after ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970499-9

7 January 2021

10.1016/S1474-4422(06)70499-9

Identifiers

DOI

1 reference

17 April 2018

PubMed ID

16857571

1 reference

17 April 2018